| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1d4d521e941cb965ee16dafedb00faf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6de5966d78d450711bfa6a4f0bb8b01 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-046 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0459
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-78 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04 |
| filingDate |
2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_242cb9a1506dc4e83326f84cdb73a207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e46f2d5b1a0e45affff2ffd4bc9c8d57 |
| publicationDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016004028-A1 |
| titleOfInvention |
2-oxopyrimidine-5-carboxylate derivatives for treating thyroid diseases |
| abstract |
The use of 2-oxopyrimidine-5-carboxylic esters and amides of formula (I): is disclosed. The compounds are agonists at the TSH receptor (TSHR) and are therefore useful in the treatment of patients with thyroid dysfunction and in the management of differentiated thyroid cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114478396-A |
| priorityDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |